Trimodality strategy for treating malignant pleural mesothelioma: results of a feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation (Japan Mesothelioma Interest Group 0601 Trial)-Reference-Cited by-同舟云学术

Trimodality strategy for treating malignant pleural mesothelioma: results of a feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation (Japan Mesothelioma Interest Group 0601 Trial)

Published:2015-11-17 Issue:3 Volume:21 Page:523-530
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:en
Short-container-title:Int J Clin Oncol

Author:

Hasegawa Seiki,Okada Morihito,Tanaka Fumihiro,Yamanaka Takeharu,Soejima Toshinori,Kamikonya Norihiko,Tsujimura Tohru,Fukuoka Kazuya,Yokoi Kohei,Nakano Takashi

Funder

the Special Coordination Funds for Promoting Science and Technology from the Japanese Ministry of Education, Culture, Sports, Science and Technology

programs for promoting clinical cancer research through a Japanese Health and Labor Sciences Research Grant

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology,General Medicine,Surgery

Link

http://link.springer.com/content/pdf/10.1007/s10147-015-0925-1.pdf

Reference35 articles.

1. Robinson BW, Musk AW, Lake RA (2005) Malignant mesothelioma. Lancet 366:397–408

2. Committee BTSSoC (2007) BTS statement on malignant mesothelioma in the UK, 2007. Thorax 62(Suppl 2):ii1–ii19